Search

everythinglearnresearchcommunity

for

Search:↓

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Autoimmune markers may help diagnose and manage PCOS.

PCOS patients have more central body fat, which can be effectively measured using DEXA.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Certain genes in fat tissue affect weight loss in women with PCOS.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Obesity is strongly linked to the severity of hirsutism in women.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Hormonal imbalances are important in the development of male pattern baldness.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Vitamin D may help improve hormone levels in women with PCOS.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.